Two formulations of epoprostenol sodium in the treatment of pulmonary arterial hypertension: EPITOME-1 (epoprostenol for injection in pulmonary arterial hypertension), a phase IV, open-label, randomized study

Kelly M. Chin, David B. Badesch, Ivan M. Robbins, Victor F. Tapson, Harold I. Palevsky, Nick H. Kim, Steven M. Kawut, Adaani Frost, Wade W. Benton, Jean Christophe Lemarie, Frederic Bodin, Lewis J. Rubin, Vallerie McLaughlin

Research output: Contribution to journalArticle

21 Scopus citations

Fingerprint Dive into the research topics of 'Two formulations of epoprostenol sodium in the treatment of pulmonary arterial hypertension: EPITOME-1 (epoprostenol for injection in pulmonary arterial hypertension), a phase IV, open-label, randomized study'. Together they form a unique fingerprint.

Medicine & Life Sciences